Antiverse

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

Absci

This biopharmaceutical company uses generative artificial intelligence to design and develop biologic medicines for pharmaceutical partners and clinical patients.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

Profluent

This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.

Abalone Bio

This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Metaphore Biotechnologies

This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.

Converge Bio

The company develops AI software for antibody design and optimization to assist pharmaceutical firms in drug discovery and development.